Solution for injection in pre-filled syringe
HM-GLP2-201
Phase 2 small_molecule active
Quick answer
Solution for injection in pre-filled syringe for Short Bowel Syndrome-associated Intestinal Failure (SBS-IF) is a Phase 2 program (small_molecule) at Pharm Research Associates (UK) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharm Research Associates (UK) Limited
- Indication
- Short Bowel Syndrome-associated Intestinal Failure (SBS-IF)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active